Effects of intravenously administered iron on systemic blood pressure in hemodialysis patients

Nephron - Clinical Practice

Volumn 98, Issue 3, 2004, Pages

  Ullian, Michael E ^a   Gadegbeku, Crystal A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Blood pressure; Hemodialysis; Intra dialytic hypotension; Intravenous iron; Iron dextran

Indexed keywords

FERROUS GLUCONATE; IRON DEXTRAN;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BACKACHE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG ERUPTION; DRUG FEVER; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPOTENSION; IRON THERAPY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT; THORAX PAIN; URBAN AREA; WHEEZING;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; BLOOD PRESSURE; FEMALE; FERRIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 8344232223     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080678     Document Type: Article

References (8)

1. St Peter WL, Lambrecht LJ, Macres M: Randomized cross-over study of adverse reactions and cost implications of intravenous push compared with infusion of iron dextran in hemodialysis patients. Am J Kidney Dis 1996;28:523-528.
2. Hoigne R, Breymann C, Kunzi UP, Brunner F: Parenteral iron therapy: Problems and possible solutions (in German). Schweiz Med Wochenschr 1998;128:528-535.
3. Fishbane S, Ungureanu VD, Maesaka JK, Kaupke CJ, Lim V, Wish J: The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 1996;28:529-534.
4. Pollak VE, Lorch JA, Means RT: Unanticipated favorable effects of correcting iron deficiency in chronic hemodialysis patients. J Investig Med 2001;49:173-183.
5. Charytan C, Levin N, Al-Saloum M, Hafeez T, Gagnon S, Van Wyck DB: Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. Am J Kidney Dis 2001;37:300-307.
6. Silverberg DS, Iaina A, Peer G, Kaplan E, Levi BA, Frank N, Steinbruch S, Blum M: Intravenous iron supplementation for the treatment of the anemia of moderate to severe chronic renal failure patients not receiving dialysis. Am J Kidney Dis 1996;27:234-238.
7. Lim PS, Wei YH, Yu YL, Kho B: Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant 1999;14:2680-2687.
8. Matsuoka H, Fukami K, Ihda S, Usui M, Okuda S, Imaizumi T: Iron causes endothelial dysfunction via oxidative stress in humans (abstract). AHA Council for HBP Res Ann Meeting, Sept, 1999.